Why Eli Lilly's Profits Aren't a Sure Thing for Marketers Despite Obesity Drug Push
Eli Lilly appears to be making as many of its popular obesity and diabetes drugs as possible, but shortages are…
Eli Lilly and company
Eli Lilly (LLY) earnings in the first quarter of 2024
The Eli Lilly logo is displayed at one of the company's offices in San Diego, California, U.S., on September 17,…
Unjustified drop after GEHC results is a buying opportunity
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
Eli Lilly (LLY) Says It Can Overcome the Problem of Too Much Demand for High Quality
Eli Lilly's improved guidance stole the show on Tuesday, offsetting mixed first-quarter results and sending shares up nearly 6%. The…
Amgen scraps experimental weight-loss pill, moves forward with shot
The Amgen logo is displayed outside of Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama |…
Amgen Soars on Progress in Weight-Loss Drugs, Novo Nordisk and Eli Lilly Fall
amgenShares rose more than 12% on Friday after the drugmaker revealed positive initial data on its experimental weight-loss shot. That…
Eli Lilly's weight-loss drug Zepbound effective in sleep apnea trials
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is displayed in New York City, U.S., on December 11,…
The promise of Eli Lilly's weight-loss drug for sleep apnea adds reasons to own it
Eli Lilly's weight-loss drug Zepbound showed promise as a treatment for sleep apnea, giving investors more confidence to continue owning…
Weight-loss drug altimmune minimized muscle loss in trial
Daniel Grill tetra images | fake images altimmune on Wednesday said its experimental drug helped patients lose weight but also…
Investment in advertising of diabetes and weight loss drugs exceeds one billion dollars
Boxes of Wegovy manufactured by Novo Nordisk in a pharmacy in London, Britain, on March 8, 2024. Hollie Adams |…